
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum Corp is poised for significant growth driven by its strategies to enhance market penetration and develop innovative solutions across its segments. The company's focus on accelerating global adoption of its antimicrobial solutions and expanding its capabilities in Revenue Cycle Management is expected to elevate the standard of care and facilitate international growth. Furthermore, continued product innovation and an emphasis on autonomous coding within the company's offerings support a robust revenue outlook, primarily stemming from its MedSurg segment.
Bears say
Solventum Corp has faced a significant decline in volume growth, recording seven consecutive quarters of negative volumes prior to any restructuring efforts, which raises concerns about its operational performance and market demand. Additionally, the company is projected to experience approximately 40 basis points of gross margin declines in 2026, primarily due to the anticipated full-year impact of tariffs, further straining its profitability. These foundational issues suggest ongoing challenges for Solventum, impacting its overall financial health and future growth prospects.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares